Mycobacterium senegalense catheter-related bloodstream infection.
Noralwani Badarol HishamMazriza MadonSiti Norbaya MasriSyafinaz Amin-NordinPublished in: BMJ case reports (2024)
Catheter-related bloodstream infection (CRBSI) is one of the common healthcare-acquired infections imposing a high burden of morbidity and mortality on the patients. Non-tuberculous mycobacterium is a rare aetiology for CRBSI and poses challenges in laboratory diagnosis and clinical management. This is a case of a woman in her early 60s with underlying end-stage renal failure, diabetes mellitus and hypertension presented with a 2-week history of high-grade fever postregular haemodialysis, vomiting, lethargy and altered mental status.Blood cultures from a permanent catheter and peripheral taken concurrently yielded Mycobacterium senegalense , identified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, which established the diagnosis of CRBSI atypically presented with concurrent acute intracranial bleeding and cerebrovascular infarction at initial presentation. She was started on a combination of oral azithromycin, oral amikacin and intravenous imipenem, and the permanent catheter was removed. Despite the treatments instituted, she developed septicaemia, acute myocardial infarction and macrophage activation-like syndrome, causing the patient's death.
Keyphrases
- end stage renal disease
- case report
- mycobacterium tuberculosis
- high grade
- acute myocardial infarction
- healthcare
- chronic kidney disease
- ultrasound guided
- peritoneal dialysis
- newly diagnosed
- ejection fraction
- blood pressure
- adipose tissue
- atrial fibrillation
- drug induced
- type diabetes
- chemotherapy induced
- gram negative
- mental health
- percutaneous coronary intervention
- randomized controlled trial
- klebsiella pneumoniae
- high dose
- heart failure
- intensive care unit
- low dose
- respiratory failure
- coronary artery disease
- insulin resistance
- escherichia coli
- social media
- patient reported outcomes
- hepatitis b virus
- study protocol
- optical coherence tomography
- clinical trial
- rectal cancer